<DOC>
	<DOCNO>NCT02355574</DOCNO>
	<brief_summary>The INTEGRATE Registry Study follow patient cutaneous melanoma DecisionDx-Melanoma gene expression assay perform . Data collect review medical record clinical visit physician . The purpose document clinical application result obtain DecisionDx- Melanoma multi-gene assay track outcome patient DecisionDx-Melanoma test complete . Additionally study ass health economic impact DecisionDx-Melanoma testing relate Melanoma population .</brief_summary>
	<brief_title>5-year Study Track Clinical Application DecisionDx-Melanoma Gene Expression Profile Assay Results</brief_title>
	<detailed_description />
	<mesh_term>Melanoma</mesh_term>
	<criteria>Patients diagnose melanoma determine , physician , appropriate DecisionDxMelanoma test successful result available investigator eligible registration Patients enrol reasonably able followup enrol physician regular interval assessment outcome data . 16 Years old Less 16 Years age</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>melanoma</keyword>
	<keyword>cutaneous melanoma</keyword>
	<keyword>DecisionDx-Melanoma</keyword>
</DOC>